<b>UHH052/05.04.2011</b><br><br>
The present invention is directed to a process for the diastereoselective synthesis of phosphorus compounds, particularly pronucleotides (nucleotide prodrugs). Pronucleotides represent a promising alternative to improve the biological activity of nucleoside analogs in antiviral and cancer chemotherapy.
Further Information: PDF
TuTech Innovation GmbH (TuTech)
Phone: +49 40 76629-6542
Contact
Dr. Markus Kähler, Dr. Stefanie Klingelhöfer, Karl-Heinz Rehfeldt, Astrid Stichnoth
